New Deal Advisors supports NB Renaissance in the partnership with Neopharmed Gentili and Ardian
Milan, 09 november 2022 – New Deal Advisors, an independent company specialising in advisory services to M&A Transactions, supported NB Renaissance in the acquisition of a majority stake in Neopharmed Gentili.
Based in Milan, Neopharmed Gentili, is one of the largest pharmaceutical companies operating in the Italian market. With one of the largest networks of medical representatives in Italy, Neopharmed Gentili has a leading position in therapeutic areas such as cardiovascular and neurology.
With the renewed agreement, the Del Bono family, Ardian and NB Renaissance lay the foundation to continue the growth path and confirm their willingness to support the company and the management team by providing new capital.
New Deal Advisors, with a team led by Antonio Ficetti Gasco (Partner), has provided Financial Due Diligence and Tax Due Diligence services to NB Renaissance.
New Deal Advisors is an independent firm specialising in advisory services in M&A. Established in 2012, New Deal Advisors provides support in a broad variety of extraordinary transactions streams including mergers and acquisitions, restructuring, transformation
processes, forensic and litigation activities, fairness opinions and valuation services. New Deal Advisors has worked for more than a decade alongside private equity funds, investment holdings, family offices, financial institutions and strategic players achieving to date the finalisation of over 200 deals.